Average Insider

Where insiders trade, we follow

Insider Buy/Sell Ratio for April 2026

Extreme outlier transactions (>3ฯƒ) are excluded.Show All Data
Ratio0.2:1
Daily Buy & Sell Volume

By Sector

By Industry

Trane Technologies plc (TT)

Simmons Donald E. โ€” Group President, Americas
Apr 30, 2026
Sale
Shares
4,593
Price
$500.00
Total Value
$2.30M
Shares Held After
3,819
% of Holdings
54.6%

Unum Group (UNM)

Ahmed Elizabeth Claire โ€” EVP, People & Communications
Apr 30, 2026
Sale
Shares
12,000
Price
$80.14
Total Value
$961.68K
Shares Held After
42,587
% of Holdings
22.0%
Apr 30, 2026
Purchase
Shares
10
Price
$17.92
Total Value
$179.20
Shares Held After
32,423
% of Holdings
0.0%
Apr 30, 2026
Purchase
Shares
10
Price
$17.91
Total Value
$179.10
Shares Held After
32,413
% of Holdings
0.0%
Apr 30, 2026
Purchase
Shares
10
Price
$17.88
Total Value
$178.80
Shares Held After
32,403
% of Holdings
0.0%
Apr 30, 2026
Purchase
Shares
10
Price
$17.85
Total Value
$178.50
Shares Held After
32,393
% of Holdings
0.0%
Apr 30, 2026
Purchase
Shares
2,000
Price
$50.00
Total Value
$100.00K
Shares Held After
2,000
% of Holdings
100.0%

Processa Pharmaceuticals, Inc. (PCSA)

Lin Patrick โ€” Chief Business - Strategy Off
Apr 30, 2026
Purchase
Shares
1,511
Price
$2.69
Total Value
$4.06K
Shares Held After
6,236
% of Holdings
24.2%
Apr 30, 2026
Purchase
Shares
2,034
Price
$2.69
Total Value
$5.47K
Shares Held After
6,013
% of Holdings
33.8%

Processa Pharmaceuticals, Inc. (PCSA)

SKIBSTED RUSSELL โ€” Chief Financial Officer
Apr 30, 2026
Purchase
Shares
2,190
Price
$2.69
Total Value
$5.89K
Shares Held After
6,498
% of Holdings
33.7%

Pershing Square USA, Ltd. (PSUS)

Gonnella Michael โ€” Chief Financial Officer
Apr 30, 2026
Purchase
Shares
100,000
Price
$50.00
Total Value
$5.00M
Shares Held After
100,000
% of Holdings
100.0%
Apr 30, 2026
Sale
Shares
50,000
Price
$68.00
Total Value
$3.40M
Shares Held After
515,681
% of Holdings
8.8%

Processa Pharmaceuticals, Inc. (PCSA)

Guy Wendy โ€” Chief Administrative Officer
Apr 30, 2026
Purchase
Shares
1,748
Price
$2.69
Total Value
$4.70K
Shares Held After
6,441
% of Holdings
27.1%

Avalo Therapeutics, Inc. (AVTX)

Sullivan Christopher Ryan โ€” Chief Financial Officer
Apr 30, 2026
Sale
Shares
8,457
Price
$13.23
Total Value
$111.85K
Shares Held After
423
% of Holdings
95.2%
Apr 30, 2026
Purchase
Shares
1,706
Price
$2.69
Total Value
$4.59K
Shares Held After
13,813
% of Holdings
12.4%
Apr 30, 2026
Sale
Shares
2,036
Price
$68.25
Total Value
$138.96K
Shares Held After
24,671
% of Holdings
7.6%

Vinci Compass Investments Ltd. (VINP)

Ribeiro Sergio Passos โ€” Chief Financial Officer
Apr 30, 2026
Sale
Shares
1,795
Price
$10.93
Total Value
$19.62K
Shares Held After
300,281
% of Holdings
0.6%

Vinci Compass Investments Ltd. (VINP)

Lovisotto Fernando โ€” Head of Global IP&S
Apr 30, 2026
Sale
Shares
4,987
Price
$10.93
Total Value
$54.51K
Shares Held After
1,100,539
% of Holdings
0.5%
Apr 30, 2026
Sale
Shares
6,000
Price
$68.16
Total Value
$408.96K
Shares Held After
136,182
% of Holdings
4.2%

SENSIENT TECHNOLOGIES CORP (SXT)

Morris Steven B โ€” President, Color Group
Apr 30, 2026
Sale
Shares
200
Price
$114.58
Total Value
$22.92K
Shares Held After
6,759
% of Holdings
2.9%

Crane Co (CR)

Lynch Susan D โ€” Director
Apr 30, 2026
Purchase
Shares
150
Price
$177.38
Total Value
$26.61K
Shares Held After
370
% of Holdings
40.5%
Apr 30, 2026
Sale
Shares
40
Price
$579.51
Total Value
$23.18K
Shares Held After
40,513
% of Holdings
0.1%
Apr 30, 2026
Sale
Shares
460
Price
$577.97
Total Value
$265.87K
Shares Held After
40,553
% of Holdings
1.1%
Apr 30, 2026
Sale
Shares
316
Price
$577.10
Total Value
$182.36K
Shares Held After
41,013
% of Holdings
0.8%
Apr 30, 2026
Sale
Shares
424
Price
$576.14
Total Value
$244.28K
Shares Held After
41,329
% of Holdings
1.0%
Apr 30, 2026
Sale
Shares
312
Price
$574.79
Total Value
$179.34K
Shares Held After
41,753
% of Holdings
0.7%
Apr 30, 2026
Sale
Shares
928
Price
$573.85
Total Value
$532.53K
Shares Held After
42,065
% of Holdings
2.2%
Apr 30, 2026
Sale
Shares
1,640
Price
$572.57
Total Value
$939.02K
Shares Held After
42,993
% of Holdings
3.7%
Apr 30, 2026
Sale
Shares
3,826
Price
$571.59
Total Value
$2.19M
Shares Held After
44,633
% of Holdings
7.9%
Apr 30, 2026
Sale
Shares
1,194
Price
$570.76
Total Value
$681.48K
Shares Held After
48,459
% of Holdings
2.4%
Apr 30, 2026
Sale
Shares
360
Price
$569.54
Total Value
$205.03K
Shares Held After
49,653
% of Holdings
0.7%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES โ€” CFO AND TREASURER
Apr 30, 2026
Sale
Shares
40
Price
$578.76
Total Value
$23.15K
Shares Held After
18,876
% of Holdings
0.2%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES โ€” CFO AND TREASURER
Apr 30, 2026
Sale
Shares
378
Price
$578.07
Total Value
$218.51K
Shares Held After
18,916
% of Holdings
2.0%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES โ€” CFO AND TREASURER
Apr 30, 2026
Sale
Shares
336
Price
$577.24
Total Value
$193.95K
Shares Held After
19,294
% of Holdings
1.7%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES โ€” CFO AND TREASURER
Apr 30, 2026
Sale
Shares
486
Price
$576.24
Total Value
$280.05K
Shares Held After
19,630
% of Holdings
2.4%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES โ€” CFO AND TREASURER
Apr 30, 2026
Sale
Shares
273
Price
$574.96
Total Value
$156.97K
Shares Held After
20,116
% of Holdings
1.3%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES โ€” CFO AND TREASURER
Apr 30, 2026
Sale
Shares
887
Price
$574.07
Total Value
$509.20K
Shares Held After
20,389
% of Holdings
4.2%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES โ€” CFO AND TREASURER
Apr 30, 2026
Sale
Shares
880
Price
$573.00
Total Value
$504.24K
Shares Held After
21,276
% of Holdings
4.0%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES โ€” CFO AND TREASURER
Apr 30, 2026
Sale
Shares
3,034
Price
$572.00
Total Value
$1.74M
Shares Held After
22,156
% of Holdings
12.0%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES โ€” CFO AND TREASURER
Apr 30, 2026
Sale
Shares
2,940
Price
$571.23
Total Value
$1.68M
Shares Held After
25,190
% of Holdings
10.5%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES โ€” CFO AND TREASURER
Apr 30, 2026
Sale
Shares
484
Price
$570.19
Total Value
$275.97K
Shares Held After
28,130
% of Holdings
1.7%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES โ€” CFO AND TREASURER
Apr 30, 2026
Sale
Shares
262
Price
$569.24
Total Value
$149.14K
Shares Held After
28,614
% of Holdings
0.9%

TEXAS INSTRUMENTS INC (TXN)

Gary Mark โ€” Sr. Vice President
Apr 30, 2026
Sale
Shares
13,689
Price
$279.25
Total Value
$3.82M
Shares Held After
45,547
% of Holdings
23.1%

TEXAS INSTRUMENTS INC (TXN)

Roberts Mark T. โ€” Sr. Vice President
Apr 30, 2026
Sale
Shares
20,294
Price
$280.72
Total Value
$5.70M
Shares Held After
53,809
% of Holdings
27.4%

TEXAS INSTRUMENTS INC (TXN)

Roberts Mark T. โ€” Sr. Vice President
Apr 30, 2026
Sale
Shares
7,786
Price
$279.34
Total Value
$2.17M
Shares Held After
74,103
% of Holdings
9.5%

Ainos, Inc. (AIMD)

chiang yao-chung โ€” Director
Apr 30, 2026
Purchase
Shares
200
Price
$1.68
Total Value
$336.00
Shares Held After
700
% of Holdings
28.6%

BELITE BIO, INC (BLTE)

MATA NATHAN L. โ€” Chief Scientific Officer
Apr 30, 2026
Sale
Shares
101
Price
$158.15
Total Value
$15.97K
Shares Held After
4,666
% of Holdings
2.1%

Bandwidth Inc. (BAND)

Ross Kade โ€” Chief Information Officer
Apr 30, 2026
Sale
Shares
1,500
Price
$33.46
Total Value
$50.19K
Shares Held After
63,894
% of Holdings
2.3%

BELITE BIO, INC (BLTE)

MATA NATHAN L. โ€” Chief Scientific Officer
Apr 30, 2026
Sale
Shares
340
Price
$157.37
Total Value
$53.51K
Shares Held After
4,767
% of Holdings
6.7%

Bandwidth Inc. (BAND)

Ross Kade โ€” Chief Information Officer
Apr 30, 2026
Sale
Shares
1,400
Price
$32.54
Total Value
$45.56K
Shares Held After
65,394
% of Holdings
2.1%
Version: v26.5.2